International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson’s Disease Clinical Trial – Yahoo Finance

International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson’s Disease Clinical Trial – Yahoo Finance
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial  Yahoo FinanceInternational Stem Cell Corporation (ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology ... read more
Source: Google NewsPublished on 2019-04-29